WNY Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
WNY Asset Management's PFE Position: Q2 2026 in Review
WNY Asset Management reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $17.2K and leaving 33,220 shares worth $800K. The position accounts for 0.07% of the portfolio, ranked #122.
WNY Asset Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.06M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- WNY Asset Management held 33,220 shares of Pfizer worth $800K as of Q2 2026.
- WNY Asset Management sold 658 Pfizer shares in Q2 2026, an estimated $17.2K.
- Pfizer made up 0.07% of WNY Asset Management's portfolio in Q2 2026, its #122 holding.
- WNY Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- WNY Asset Management's Pfizer position peaked at $3.06M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on WNY Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.